GO:0005344 oxygen carrier activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005344 oxygen carrier activity describes the molecular function of reversibly binding and transporting oxygen, a process essential for cellular respiration and energy metabolism.
• Key oxygen carrier proteins include hemoglobin (HBA1, HBB), myoglobin (MB), neuroglobin (NGB), cytoglobin (CYGB), and mitochondrial carriers such as cytochrome c oxidase subunits.
• Oxygen carrier activity is critical in tissues with high metabolic demand, including cardiac muscle, where PKM1 supports remodeling under pressure overload.
• Hypoxia and mitochondrial dysfunction are linked to oxygen carrier activity, influencing diseases such as osteoarthritis and cancer.
• Experimental models for studying oxygen carrier activity include knockout mice, point-mutation knock-ins, and overexpression systems using CRISPR/Cas9.
• EDITGENE provides CRISPR services to interrogate oxygen carrier genes, from KO to knock-in and library screening, accelerating discovery in hypoxia-related diseases.
Description
Oxygen carrier activity (GO:0005344) is a molecular function that enables the reversible binding and transport of molecular oxygen, a process fundamental to aerobic life. This activity is mediated by specialized proteins such as hemoglobin and myoglobin, which facilitate oxygen delivery to tissues and mitochondria for oxidative phosphorylation. Researchers study oxygen carrier activity to understand how cells adapt to hypoxia, maintain energy homeostasis, and respond to metabolic stress. Dysregulation of oxygen carrier proteins is implicated in a range of pathologies, including cardiovascular diseases, cancer, and osteoarthritis. The importance of oxygen carrier activity extends to therapeutic development, where modulating oxygen delivery can enhance radiosensitivity in tumors or protect ischemic tissues. This article provides a comprehensive overview of the genes, mechanisms, and research methods associated with GO:0005344, based on authoritative QuickGO data and verified PubMed literature.
oxygen carrier activity At A Glance
| GO ID | GO:0005344 |
|---|---|
| GO term | oxygen carrier activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Reversible binding and transport of oxygen |
| Key proteins | Hemoglobin, myoglobin, neuroglobin, cytoglobin |
| Associated diseases | Hypoxia, cancer, cardiovascular disease, osteoarthritis |
| Research methods | CRISPR KO, knock-in, overexpression, Ribo-seq, proteomics |
What Is GO:0005344?
Oxygen carrier activity (GO:0005344) is defined as the molecular function of binding oxygen and transporting it within an organism or cell. This activity is typically performed by metalloproteins or heme-containing proteins that can reversibly coordinate O2, allowing oxygen to be picked up in high-oxygen environments (e.g., lungs) and released in low-oxygen tissues (e.g., muscle). The function is essential for aerobic respiration and is conserved across many species.
Why Is oxygen carrier activity Important in Cell Biology?
Oxygen carrier activity is vital for sustaining aerobic metabolism and energy production in multicellular organisms. It ensures that oxygen reaches mitochondria for ATP synthesis, and its dysfunction leads to tissue hypoxia, oxidative stress, and cell death. Understanding this activity is crucial for developing therapies for ischemic diseases, cancer, and metabolic disorders.
• Enables oxygen delivery to tissues for oxidative phosphorylation and ATP production.
• Critical for cardiac function and remodeling under pressure overload.
• Modulates tumor response to radiotherapy via oxygen availability.
• Involved in hypoxia signaling pathways that regulate cell survival.
• Linked to mitochondrial ROS regulation and thermogenesis.
• Plays a role in mechanosignaling and mitohormesis in adherent cells.
• Target for hypoxia-targeted siRNA delivery in cancer therapy.
• Essential for T cell function in ovarian cancer through mitochondrial activity.
• Affects osteoarthritis progression via cuproptosis and hypoxia crosstalk.
• Provides a basis for CRISPR-based disease modeling and drug discovery.
Molecular Mechanism of oxygen carrier activity
Oxygen Binding and Coordination
In simple terms: Oxygen carrier proteins grab oxygen molecules using a special metal center.
Oxygen carrier proteins typically contain a heme prosthetic group with a central iron atom that reversibly binds O2. In hemoglobin, cooperative binding allows efficient oxygen uptake in the lungs and release in tissues. The binding affinity is modulated by factors such as pH, CO2, and 2,3-BPG, enabling fine-tuned oxygen delivery.
Structural Changes and Cooperativity
In simple terms: When one oxygen binds, the protein changes shape to make it easier for more oxygen to bind.
Hemoglobin exhibits positive cooperativity: binding of O2 to one subunit induces conformational changes that increase the affinity of remaining subunits. This allosteric mechanism ensures a sigmoidal oxygen dissociation curve, optimizing oxygen transport.
Cellular Oxygen Sensing and Regulation
In simple terms: Cells sense oxygen levels and adjust carrier production accordingly.
Hypoxia-inducible factors (HIFs) regulate the expression of oxygen carrier proteins and glycolytic enzymes under low oxygen. Mitochondrial ROS and metabolites can stabilize HIFs, linking oxygen carrier activity to cellular energy status.
Mitochondrial Oxygen Utilization
In simple terms: Oxygen carriers deliver oxygen to mitochondria, where it is used to make energy.
Cytochrome c oxidase (Complex IV) receives oxygen from carriers and reduces it to water, driving the proton gradient for ATP synthesis. This process is tightly coupled to oxygen carrier activity and mitochondrial function.
Regulation by Metabolic Pathways
In simple terms: Metabolic signals like mTOR and AMPK influence how much oxygen carrier is made.
The TSC2-mTOR pathway senses energy and oxygen availability to control cell growth and survival, indirectly affecting oxygen carrier demand. PKM1, a pyruvate kinase isoform, supports cardiac remodeling under pressure overload, highlighting metabolic integration.
Key Genes Involved in GO:0005344 oxygen carrier activity
The following genes encode proteins with oxygen carrier activity or closely related functions, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HBA1 | Alpha-globin subunit of hemoglobin; binds oxygen | Mutations cause alpha-thalassemia; model for oxygen transport |
| HBB | Beta-globin subunit of hemoglobin; binds oxygen | Sickle cell disease and beta-thalassemia research |
| MB | Myoglobin; stores oxygen in muscle | Cardiac and skeletal muscle oxygen storage |
| NGB | Neuroglobin; oxygen carrier in neurons | Neuroprotection and hypoxia response |
| CYGB | Cytoglobin; oxygen carrier in fibroblasts | Fibrosis and cancer hypoxia |
| HIF1A | Hypoxia-inducible factor 1-alpha; regulates oxygen homeostasis | Cancer, ischemia, and metabolic adaptation |
| EPAS1 | Endothelial PAS domain protein 1; hypoxia sensor | High-altitude adaptation and cancer |
| VHL | Von Hippel-Lindau; targets HIF for degradation | Renal cell carcinoma and hypoxia signaling |
| PKM | Pyruvate kinase M1/2; glycolytic enzyme | Cardiac remodeling and cancer metabolism |
| TSC2 | Tuberous sclerosis complex 2; mTOR regulator | Energy sensing and cell growth |
| IRE1A | ER stress sensor; regulates mitochondrial activity | T cell function in ovarian cancer |
| XBP1 | Transcription factor downstream of IRE1 | Mitochondrial activity and immune response |
| UCP1 | Uncoupling protein 1; thermogenesis | Mitochondrial ROS and energy expenditure |
| COX4I1 | Cytochrome c oxidase subunit 4 isoform 1 | Mitochondrial oxygen utilization |
| NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | Complex I and oxygen metabolism |
| SDHB | Succinate dehydrogenase complex iron sulfur subunit B | TCA cycle and oxygen sensing |
| LDHA | Lactate dehydrogenase A; anaerobic glycolysis | Hypoxia and cancer metabolism |
How Is oxygen carrier activity Regulated?
Oxygen carrier activity is regulated at multiple levels. Hypoxia-inducible factors (HIFs) control the transcription of genes encoding oxygen carriers and glycolytic enzymes in response to low oxygen. The TSC2-mTOR pathway integrates energy and oxygen signals to regulate cell growth and survival. Mitochondrial ROS can stabilize HIFs and modulate oxygen carrier function. Additionally, the IRE1α-XBP1 axis influences mitochondrial activity and oxygen consumption in immune cells.
oxygen carrier activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HBB | Sickle cell disease, beta-thalassemia | Point mutation knock-in mice |
| PKM | Cardiac remodeling under pressure overload | Cardiac-specific knockout |
| IRE1A | Ovarian cancer immune evasion | Conditional knockout in T cells |
| UCP1 | Obesity and thermogenesis | UCP1 knockout mice |
| HIF1A | Cancer, ischemia | Hypoxia-inducible overexpression |
Oxygen Carrier Activity in Cancer
Tumors often adapt to hypoxia by upregulating oxygen carrier proteins and glycolytic enzymes. Hypoxia-targeted siRNA delivery can silence oxygen carrier genes to enhance radiosensitivity. Nano-haemoglobin-based oxygen carriers increase radiosensitivity in non-small-cell lung cancer by improving oxygenation. IRE1α-XBP1 signaling controls T cell function in ovarian cancer by regulating mitochondrial activity, linking oxygen metabolism to immune evasion.
Cardiovascular and Metabolic Diseases
PKM1 exerts critical roles in cardiac remodeling under pressure overload, affecting oxygen consumption and metabolic adaptation. Mitochondrial ROS regulate thermogenic energy expenditure via UCP1 sulfenylation, connecting oxygen carrier activity to obesity and metabolic disorders. TSC2 mutations lead to mTOR dysregulation and altered oxygen sensing in tuberous sclerosis.
Osteoarthritis and Hypoxia
Hypoxia and cuproptosis crosstalk in osteoarthritis, where oxygen carrier activity influences cartilage homeostasis and cell death. Adhesion-mediated mechanosignaling forces mitohormesis, affecting mitochondrial function and oxygen utilization in joint tissues.
From oxygen carrier activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HBB affect oxygen transport? | HBB knockout zebrafish or mice |
| Can a point mutation in HBA1 alter oxygen affinity? | CRISPR knock-in of HBA1 mutation |
| Does overexpression of NGB protect neurons from hypoxia? | NGB transgenic mice |
| How does PKM1 deletion impact cardiac remodeling? | Cardiac-specific PKM1 knockout |
| Does IRE1α-XBP1 axis regulate mitochondrial oxygen consumption? | IRE1A knockout T cells |
| Can nano-haemoglobin enhance radiosensitivity? | Xenograft tumor models with oxygen carrier |
How to Study the oxygen carrier activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR KO | Gene function loss | Validate oxygen carrier genes |
| Point mutation knock-in | Specific amino acid changes | Model hemoglobinopathies |
| RNA-seq | Transcriptional changes | Hypoxia response profiling |
| Proteomics | Protein abundance and modifications | Oxygen carrier expression |
| Seahorse assay | Mitochondrial respiration | Oxygen consumption rate |
| ROS detection | Oxidative stress | Mitochondrial dysfunction |
| Tumor xenograft | In vivo tumor growth | Radiosensitivity with oxygen carriers |
| Hypoxia chamber | Cellular response to low O2 | HIF stabilization |
CRISPR/Cas9 Genome Editing
CRISPR/Cas9 enables precise knockout, knock-in, or point mutations in oxygen carrier genes to study their function in vitro and in vivo. This approach is essential for validating causal roles in hypoxia-related diseases.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can quantify expression changes in oxygen carrier genes under hypoxia or metabolic stress. These methods identify downstream pathways and biomarkers.
Mitochondrial Function Assays
Seahorse respirometry and ROS measurements assess mitochondrial oxygen consumption and efficiency, linking carrier activity to cellular energetics.
In Vivo Hypoxia Models
Animal models of ischemia, tumor xenografts, and high-altitude exposure are used to study oxygen carrier activity in physiological and pathological contexts.
How CRISPR Can Be Used to Study GO:0005344 oxygen carrier activity
Knockout
CRISPR knockout of oxygen carrier genes (e.g., HBB, MB) creates loss-of-function models to study oxygen transport defects and compensatory mechanisms.
Point Mutation
Introducing specific point mutations (e.g., HBB sickle mutation) via CRISPR allows precise modeling of hemoglobinopathies and oxygen affinity changes.
Knock-in
Knock-in of reporter tags or human orthologs enables tracking of oxygen carrier expression and function in vivo.
Overexpression
CRISPR activation or transgenic overexpression of oxygen carriers (e.g., NGB, CYGB) tests protective effects against hypoxia and oxidative stress.
How EDITGENE Supports oxygen carrier activity Research
Researchers studying oxygen carrier activity-related genes often need to determine whether a candidate gene is causally involved in oxygen transport, hypoxia adaptation, or disease progression. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell and animal models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for oxygen carrier activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MB Knockout HEK293 Cell Line | EDJ-KQ2388 | Human | 4151 | Details Get a Quote |
| HBB Knockout HEK293 Cell Line | EDJ-KQ3886 | Human | 3043 | Details Get a Quote |
| HBM Knockout HEK293 Cell Line | EDJ-KQ4845 | Human | 3042 | Details Get a Quote |
| HBD Knockout HEK293 Cell Line | EDJ-KQ4846 | Human | 3045 | Details Get a Quote |
| HBE1 Knockout HEK293 Cell Line | EDJ-KQ4847 | Human | 3046 | Details Get a Quote |
| HBQ1 Knockout HEK293 Cell Line | EDJ-KQ4848 | Human | 3049 | Details Get a Quote |
| HBZ Knockout HEK293 Cell Line | EDJ-KQ4853 | Human | 3050 | Details Get a Quote |
| CYGB Knockout HEK293 Cell Line | EDJ-KQ7452 | Human | 114757 | Details Get a Quote |
| NGB Knockout HEK293 Cell Line | EDJ-KQ12053 | Human | 58157 | Details Get a Quote |
| MB Knockout A-549 Cell Line | EDJ-KQ22868 | Human | 4151 | Details Get a Quote |
| MB Knockout HeLa Cell Line | EDJ-KQ22869 | Human | 4151 | Details Get a Quote |
| HBE1 Knockout A-549 Cell Line | EDJ-KQ27627 | Human | 3046 | Details Get a Quote |
| HBE1 Knockout HCT 116 Cell Line | EDJ-KQ27628 | Human | 3046 | Details Get a Quote |
| HBQ1 Knockout A-549 Cell Line | EDJ-KQ27629 | Human | 3049 | Details Get a Quote |
| CYGB Knockout A-549 Cell Line | EDJ-KQ31305 | Human | 114757 | Details Get a Quote |
Displaying Records 1 To 15 Of 56 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About oxygen carrier activity
What is oxygen carrier activity?
Oxygen carrier activity (GO:0005344) is the molecular function of reversibly binding and transporting oxygen, typically performed by heme-containing proteins like hemoglobin and myoglobin.
What genes are involved in oxygen carrier activity?
Key genes include HBA1, HBB, MB, NGB, CYGB, and mitochondrial genes such as COX4I1 and NDUFS1.
How is oxygen carrier activity regulated?
It is regulated by hypoxia-inducible factors (HIFs), mTOR signaling, and mitochondrial ROS, which adjust carrier expression and function.
What diseases are associated with oxygen carrier activity?
Diseases include sickle cell disease, beta-thalassemia, cancer, cardiovascular disorders, and osteoarthritis.
How can CRISPR be used to study oxygen carrier activity?
CRISPR enables knockout, knock-in, and point mutations in oxygen carrier genes to model diseases and validate function.
What methods measure oxygen carrier activity?
Methods include Ribo-seq, proteomics, Seahorse respirometry, ROS detection, and in vivo hypoxia models.
What is the role of hemoglobin in oxygen transport?
Hemoglobin binds oxygen in the lungs and releases it in tissues, with cooperative binding ensuring efficient delivery.
Can oxygen carrier activity be targeted for cancer therapy?
Yes, hypoxia-targeted siRNA and nano-haemoglobin oxygen carriers can enhance radiosensitivity in tumors.
What is the link between oxygen carrier activity and mitochondria?
Oxygen carriers deliver O2 to mitochondria for oxidative phosphorylation, and mitochondrial ROS can feedback on carrier regulation.
How does EDITGENE support oxygen carrier research?
EDITGENE provides CRISPR KO, point mutation, knock-in, overexpression, library screening, and bioinformatics services for oxygen carrier genes.
Conclusion
Oxygen carrier activity (GO:0005344) is a fundamental molecular function that sustains aerobic metabolism and is implicated in numerous diseases, from hemoglobinopathies to cancer and osteoarthritis. Understanding its genetic and biochemical regulation offers therapeutic opportunities. EDITGENE's CRISPR services empower researchers to dissect oxygen carrier gene function with precision, accelerating translation from bench to bedside.
References
- 1. Jiang Z et al.. 2025. Hypoxia, cuproptosis, and osteoarthritis: Unraveling the molecular crosstalk.. Redox Biol 85:103757 PMID: 40669206
- 2. Inoki K et al.. 2003. TSC2 mediates cellular energy response to control cell growth and survival.. Cell 115(5):577-90 PMID: 14651849
- 3. Li Q et al.. 2021. PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart.. Circulation 144(9):712-727 PMID: 34102853
- 4. Song M et al.. 2018. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.. Nature 562(7727):423-428 PMID: 30305738
- 5. Chouchani ET et al.. 2016. Mitochondrial ROS regulate thermogenic energy expenditure and sulfenylation of UCP1.. Nature 532(7597):112-6 PMID: 27027295
- 6. Perche F et al.. 2014. Hypoxia-targeted siRNA delivery.. Angew Chem Int Ed Engl 53(13):3362-6 PMID: 24554550
- 7. Tharp KM et al.. 2021. Adhesion-mediated mechanosignaling forces mitohormesis.. Cell Metab 33(7):1322-1341.e13 PMID: 34019840
- 8. Liu C et al.. 2025. Nano-haemoglobin-based oxygen carrier increases the radiosensitivity of non-small-cell lung cancer.. Artif Cells Nanomed Biotechnol 53(1):244-252 PMID: 40451212
